This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meyers, S Articles by Hiebert, S W Search for Related Content PubMed PubMed Citation Articles by Meyers, S Articles by Hiebert, S W

Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions.

Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.

ABSTRACT

The AML1 gene on chromosome 21 is disrupted in the (8;21)(q22;q22) translocation associated with acute myelogenous leukemia and encodes a protein with a central 118-amino-acid domain with 69% homology to the Drosophila pair-rule gene, runt. We demonstrate that AML-1 is a DNA-binding protein which specifically interacts with a sequence belonging to the group of enhancer core motifs, TGT/cGGT. Electrophoretic mobility shift analysis of cell extracts identified two AML-1-containing protein-DNA complexes whose electrophoretic mobilities were slower than those of complexes formed with AML-1 produced in vitro. Mixing of in vitro-produced AML-1 with cell extracts prior to gel mobility shift analysis resulted in the formation of higher-order complexes. Deletion mutagenesis of AML-1 revealed that the runt homology domain mediates both sequence-specific DNA binding and protein-protein interactions. The hybrid product, AML-1/ETO, which results from the (8;21) translocation and retains the runt homology domain, both recognizes the AML-1 consensus sequence and interacts with other cellular proteins.

This article has been cited by other articles:

• Endo, T., Ohta, K., Kobayashi, T. (2008). Expression and Function of Cbfa-1/Runx2 in Thyroid Papillary Carcinoma Cells. J. Clin. Endocrinol. Metab. 93: 2409-2412 [Abstract] [Full Text]  
• Ogawa, S., Satake, M., Ikuta, K. (2008). Physical and Functional Interactions between STAT5 and Runx Transcription Factors. J Biochem 143: 695-709 [Abstract] [Full Text]  
• Roca, H., Franceschi, R. T. (2008). Analysis of transcription factor interactions in osteoblasts using competitive chromatin immunoprecipitation. Nucleic Acids Res 36: 1723-1730 [Abstract] [Full Text]  
• Zhang, L., Fried, F. B., Guo, H., Friedman, A. D. (2008). Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood 111: 1193-1200 [Abstract] [Full Text]  
• Hollenhorst, P. C., Shah, A. A., Hopkins, C., Graves, B. J. (2007). Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev. 21: 1882-1894 [Abstract] [Full Text]  
• Peterson, L. F., Yan, M., Zhang, D.-E. (2007). The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO. Blood 109: 4392-4398 [Abstract] [Full Text]  
• Ma, L.-H., Liu, H., Xiong, H., Chen, B., Zhang, X.-W., Wang, Y.-Y., Le, H.-Y., Huang, Q.-H., Zhang, Q.-H., Li, B.-L., Chen, Z., Chen, S.-J. (2007). Aberrant transcriptional regulation of the MLL fusion partner EEN by AML1-ETO and its implication in leukemogenesis. Blood 109: 769-777 [Abstract] [Full Text]  
• Biggs, J. R., Peterson, L. F., Zhang, Y., Kraft, A. S., Zhang, D.-E. (2006). AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex. Mol. Cell. Biol. 26: 7420-7429 [Abstract] [Full Text]  
• Abe, N., Kohu, K., Ohmori, H., Hayashi, K., Watanabe, T., Hozumi, K., Sato, T., Habu, S., Satake, M. (2005). Reduction of Runx1 Transcription Factor Activity Up-Regulates Fas and Bim Expression and Enhances the Apoptotic Sensitivity of Double Positive Thymocytes. J. Immunol. 175: 4475-4482 [Abstract] [Full Text]  
• Celil, A. B., Campbell, P. G. (2005). BMP-2 and Insulin-like Growth Factor-I Mediate Osterix (Osx) Expression in Human Mesenchymal Stem Cells via the MAPK and Protein Kinase D Signaling Pathways. J. Biol. Chem. 280: 31353-31359 [Abstract] [Full Text]  
• Senyuk, V., Li, D., Zakharov, A., Mikhail, F. M., Nucifora, G. (2005). The Distal Zinc Finger Domain of AML1/MDS1/EVI1 Is an Oligomerization Domain Involved in Induction of Hematopoietic Differentiation Defects in Primary Cells In vitro. Cancer Res. 65: 7603-7611 [Abstract] [Full Text]  
• Chen, S., Rani, S., Wu, Y., Unterbrink, A., Gu, T. T., Gluhak-Heinrich, J., Chuang, H.-H., MacDougall, M. (2005). Differential Regulation of Dentin Sialophosphoprotein Expression by Runx2 during Odontoblast Cytodifferentiation. J. Biol. Chem. 280: 29717-29727 [Abstract] [Full Text]  
• Yang, G., Khalaf, W., van de Locht, L., Jansen, J. H., Gao, M., Thompson, M. A., van der Reijden, B. A., Gutmann, D. H., Delwel, R., Clapp, D. W., Hiebert, S. W. (2005). Transcriptional Repression of the Neurofibromatosis-1 Tumor Suppressor by the t(8;21) Fusion Protein. Mol. Cell. Biol. 25: 5869-5879 [Abstract] [Full Text]  
• Fukushima-Nakase, Y., Naoe, Y., Taniuchi, I., Hosoi, H., Sugimoto, T., Okuda, T. (2005). Shared and distinct roles mediated through C-terminal subdomains of acute myeloid leukemia/Runt-related transcription factor molecules in murine development. Blood 105: 4298-4307 [Abstract] [Full Text]  
• Liu, S., Shen, T., Huynh, L., Klisovic, M. I., Rush, L. J., Ford, J. L., Yu, J., Becknell, B., Li, Y., Liu, C., Vukosavljevic, T., Whitman, S. P., Chang, K.-S., Byrd, J. C., Perrotti, D., Plass, C., Marcucci, G. (2005). Interplay of RUNX1/MTG8 and DNA Methyltransferase 1 in Acute Myeloid Leukemia. Cancer Res. 65: 1277-1284 [Abstract] [Full Text]  
• Nguyen, L. A., Pandolfi, P. P., Aikawa, Y., Tagata, Y., Ohki, M., Kitabayashi, I. (2005). Physical and functional link of the leukemia-associated factors AML1 and PML. Blood 105: 292-300 [Abstract] [Full Text]  
• Planaguma, J., Diaz-Fuertes, M., Gil-Moreno, A., Abal, M., Monge, M., Garcia, A., Baro, T., Thomson, T. M., Xercavins, J., Alameda, F., Reventos, J. (2004). A Differential Gene Expression Profile Reveals Overexpression of RUNX1/AML1 in Invasive Endometrioid Carcinoma. Cancer Res. 64: 8846-8853 [Abstract] [Full Text]  
• Schroeder, T. M., Kahler, R. A., Li, X., Westendorf, J. J. (2004). Histone Deacetylase 3 Interacts with Runx2 to Repress the Osteocalcin Promoter and Regulate Osteoblast Differentiation. J. Biol. Chem. 279: 41998-42007 [Abstract] [Full Text]  
• Barski, A., Frenkel, B. (2004). ChIP Display: novel method for identification of genomic targets of transcription factors. Nucleic Acids Res 32: e104-e104 [Abstract] [Full Text]  
• Nielsen, C, Laustrup, H, Voss, A, Junker, P, Husby, S, Lillevang, S T (2004). A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients. Lupus 13: 510-516 [Abstract]  
• Asakura, K., Uchida, H., Miyachi, H., Kobayashi, H., Miyakawa, Y., Nimer, S. D., Takahashi, H., Ikeda, Y., Kizaki, M. (2004). TEL/AML1 Overcomes Drug Resistance Through Transcriptional Repression of Multidrug Resistance-1 Gene Expression. Mol Cancer Res 2: 339-347 [Abstract] [Full Text]  
• Yamaguchi, Y., Kurokawa, M., Imai, Y., Izutsu, K., Asai, T., Ichikawa, M., Yamamoto, G., Nitta, E., Yamagata, T., Sasaki, K., Mitani, K., Ogawa, S., Chiba, S., Hirai, H. (2004). AML1 Is Functionally Regulated through p300-mediated Acetylation on Specific Lysine Residues. J. Biol. Chem. 279: 15630-15638 [Abstract] [Full Text]  
• Bernardin-Fried, F., Kummalue, T., Leijen, S., Collector, M. I., Ravid, K., Friedman, A. D. (2004). AML1/RUNX1 Increases During G1 to S Cell Cycle Progression Independent of Cytokine-dependent Phosphorylation and Induces Cyclin D3 Gene Expression. J. Biol. Chem. 279: 15678-15687 [Abstract] [Full Text]  
• Yamamoto, C. M., Banaiee, N., Yount, N. Y., Patel, B., Selsted, M. E. (2004). {alpha}-Defensin expression during myelopoiesis: identification of cis and trans elements that regulate expression of NP-3 in rat promyelocytes. J. Leukoc. Biol. 75: 332-341 [Abstract] [Full Text]  
• Li, F.-Q., Person, R. E., Takemaru, K.-I., Williams, K., Meade-White, K., Ozsahin, A. H., Gungor, T., Moon, R. T., Horwitz, M. (2004). Lymphoid Enhancer Factor-1 Links Two Hereditary Leukemia Syndromes through Core-binding Factor {alpha} Regulation of ELA2. J. Biol. Chem. 279: 2873-2884 [Abstract] [Full Text]  
• Nishimura, M., Fukushima-Nakase, Y., Fujita, Y., Nakao, M., Toda, S., Kitamura, N., Abe, T., Okuda, T. (2004). VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development. Blood 103: 562-570 [Abstract] [Full Text]  
• Hug, B. A., Ahmed, N., Robbins, J. A., Lazar, M. A. (2004). A Chromatin Immunoprecipitation Screen Reveals Protein Kinase C{beta} as a Direct RUNX1 Target Gene. J. Biol. Chem. 279: 825-830 [Abstract] [Full Text]  
• Zhang, L., Li, Z., Yan, J., Pradhan, P., Corpora, T., Cheney, M. D., Bravo, J., Warren, A. J., Bushweller, J. H., Speck, N. A. (2003). Mutagenesis of the Runt Domain Defines Two Energetic Hot Spots for Heterodimerization with the Core Binding Factor {beta} Subunit. J. Biol. Chem. 278: 33097-33104 [Abstract] [Full Text]  
• Komine, O., Hayashi, K., Natsume, W., Watanabe, T., Seki, Y., Seki, N., Yagi, R., Sukzuki, W., Tamauchi, H., Hozumi, K., Habu, S., Kubo, M., Satake, M. (2003). The Runx1 Transcription Factor Inhibits the Differentiation of Naive CD4+ T Cells into the Th2 Lineage by Repressing GATA3 Expression. J. Exp. Med. 198: 51-61 [Abstract] [Full Text]  
• Stams, W. A. G., den Boer, M. L., Beverloo, H. B., Meijerink, J. P. P., Stigter, R. L., van Wering, E. R., Janka-Schaub, G. E., Slater, R., Pieters, R. (2003). Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood 101: 2743-2747 [Abstract] [Full Text]  
• Kahler, R. A., Westendorf, J. J. (2003). Lymphoid Enhancer Factor-1 and beta -Catenin Inhibit Runx2-dependent Transcriptional Activation of the Osteocalcin Promoter. J. Biol. Chem. 278: 11937-11944 [Abstract] [Full Text]  
• Kalev-Zylinska, M. L., Horsfield, J. A., Flores, M. V. C., Postlethwait, J. H., Vitas, M. R., Baas, A. M., Crosier, P. S., Crosier, K. E. (2003). Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 129: 2015-2030 [Abstract] [Full Text]  
• Guyot, B., Mouchiroud, G. (2003). Characterization of promoter elements directing Mona/Gads molecular adapter expression in T and myelomonocytic cells: involvement of the AML-1 transcription factor. J. Leukoc. Biol. 73: 263-272 [Abstract] [Full Text]  
• Tonks, A., Pearn, L., Tonks, A. J., Pearce, L., Hoy, T., Phillips, S., Fisher, J., Downing, J. R., Burnett, A. K., Darley, R. L. (2003). The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells. Blood 101: 624-632 [Abstract] [Full Text]  
• Vangala, R. K., Heiss-Neumann, M. S., Rangatia, J. S., Singh, S. M., Schoch, C., Tenen, D. G., Hiddemann, W., Behre, G. (2003). The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood 101: 270-277 [Abstract] [Full Text]  
• Kummalue, T., Lou, J., Friedman, A. D. (2002). Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBF{beta}-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein. Mol. Cell. Biol. 22: 8278-8291 [Abstract] [Full Text]  
• Westendorf, J. J., Zaidi, S. K., Cascino, J. E., Kahler, R., van Wijnen, A. J., Lian, J. B., Yoshida, M., Stein, G. S., Li, X. (2002). Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter. Mol. Cell. Biol. 22: 7982-7992 [Abstract] [Full Text]  
• Schwieger, M., Lohler, J., Friel, J., Scheller, M., Horak, I., Stocking, C. (2002). AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency. J. Exp. Med. 196: 1227-1240 [Abstract] [Full Text]  
• de Guzman, C. G., Warren, A. J., Zhang, Z., Gartland, L., Erickson, P., Drabkin, H., Hiebert, S. W., Klug, C. A. (2002). Hematopoietic Stem Cell Expansion and Distinct Myeloid Developmental Abnormalities in a Murine Model of the AML1-ETO Translocation. Mol. Cell. Biol. 22: 5506-5517 [Abstract] [Full Text]  
• Michaud, J., Wu, F., Osato, M., Cottles, G. M., Yanagida, M., Asou, N., Shigesada, K., Ito, Y., Benson, K. F., Raskind, W. H., Rossier, C., Antonarakis, S. E., Israels, S., McNicol, A., Weiss, H., Horwitz, M., Scott, H. S. (2002). In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood 99: 1364-1372 [Abstract] [Full Text]  
• Hayashi, K., Abe, N., Watanabe, T., Obinata, M., Ito, M., Sato, T., Habu, S., Satake, M. (2001). Overexpression of AML1 Transcription Factor Drives Thymocytes into the CD8 Single-Positive Lineage. J. Immunol. 167: 4957-4965 [Abstract] [Full Text]  
• Liu, S., Guo, R., Quarles, L. D. (2001). Cloning and Characterization of the Proximal Murine Phex Promoter. Endocrinology 142: 3987-3995 [Abstract] [Full Text]  
• Burel, S. A., Harakawa, N., Zhou, L., Pabst, T., Tenen, D. G., Zhang, D.-E. (2001). Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation. Mol. Cell. Biol. 21: 5577-5590 [Abstract] [Full Text]  
• Kaminker, J. S., Singh, R., Lebestky, T., Yan, H., Banerjee, U. (2001). Redundant function of Runt Domain binding partners, Big brother and Brother, during Drosophila development. Development 128: 2639-2648 [Abstract] [Full Text]  
• Mertz, J. A., Mustafa, F., Meyers, S., Dudley, J. P. (2001). Type B Leukemogenic Virus Has a T-Cell-Specific Enhancer That Binds AML-1. J. Virol. 75: 2174-2184 [Abstract] [Full Text]  
• Zaidi, S. K., Javed, A., Choi, J.-Y., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S. (2001). A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci. 114: 3093-3102 [Abstract] [Full Text]  
• Hayashi, K., Natsume, W., Watanabe, T., Abe, N., Iwai, N., Okada, H., Ito, Y., Asano, M., Iwakura, Y., Habu, S., Takahama, Y., Satake, M. (2000). Diminution of the AML1 Transcription Factor Function Causes Differential Effects on the Fates of CD4 and CD8 Single-Positive T Cells. J. Immunol. 165: 6816-6824 [Abstract] [Full Text]  
• Vilches, C., Gardiner, C. M., Parham, P. (2000). Gene Structure and Promoter Variation of Expressed and Nonexpressed Variants of the KIR2DL5 Gene. J. Immunol. 165: 6416-6421 [Abstract] [Full Text]  
• Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Takeuchi, K., Maki, K., Ogawa, S., Chiba, S., Mitani, K., Hirai, H. (2000). Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood 96: 3154-3160 [Abstract] [Full Text]  
• Rhoades, K. L., Hetherington, C. J., Harakawa, N., Yergeau, D. A., Zhou, L., Liu, L.-Q., Little, M.-T., Tenen, D. G., Zhang, D.-E. (2000). Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood 96: 2108-2115 [Abstract] [Full Text]  
• Shimada, H., Ichikawa, H., Nakamura, S., Katsu, R., Iwasa, M., Kitabayashi, I., Ohki, M. (2000). Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. Blood 96: 655-663 [Abstract] [Full Text]  
• MITANI, Y., ZAIDI, S. H. E., DUFOURCQ, P., THOMPSON, K., RABINOVITCH, M. (2000). Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning. FASEB J. 14: 805-814 [Abstract] [Full Text]  
• Javed, A, Guo, B, Hiebert, S, Choi, J., Green, J, Zhao, S., Osborne, M., Stifani, S, Stein, J., Lian, J., van Wijnen, A., Stein, G. (2000). Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J. Cell Sci. 113: 2221-2231 [Abstract]  
• Gu, T.-L., Goetz, T. L., Graves, B. J., Speck, N. A. (2000). Auto-Inhibition and Partner Proteins, Core-Binding Factor beta (CBFbeta ) and Ets-1, Modulate DNA Binding by CBFalpha 2 (AML1). Mol. Cell. Biol. 20: 91-103 [Abstract] [Full Text]  
• Okuda, T., Takeda, K., Fujita, Y., Nishimura, M., Yagyu, S., Yoshida, M., Akira, S., Downing, J. R., Abe, T. (2000). Biological Characteristics of the Leukemia-Associated Transcriptional Factor AML1 Disclosed by Hematopoietic Rescue of AML1-Deficient Embryonic Stem Cells by Using a Knock-in Strategy. Mol. Cell. Biol. 20: 319-328 [Abstract] [Full Text]  
• McNeil, S., Zeng, C., Harrington, K. S., Hiebert, S., Lian, J. B., Stein, J. L., van Wijnen, A. J., Stein, G. S. (1999). The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha 2 transcription factor. Proc. Natl. Acad. Sci. USA 96: 14882-14887 [Abstract] [Full Text]  
• Libermann, T. A., Pan, Z., Akbarali, Y., Hetherington, C. J., Boltax, J., Yergeau, D. A., Zhang, D.-E. (1999). AML1 (CBFalpha 2) Cooperates with B Cell-specific Activating Protein (BSAP/PAX5) in Activation of the B Cell-specific BLK Gene Promoter. J. Biol. Chem. 274: 24671-24676 [Abstract] [Full Text]  
• Le, X.-F., Groner, Y., Kornblau, S. M., Gu, Y., Hittelman, W. N., Levanon, D., Mehta, K., Arlinghaus, R. B., Chang, K.-S. (1999). Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor alpha -Dependent Signaling Pathway. J. Biol. Chem. 274: 21651-21658 [Abstract] [Full Text]  
• Redner, R. L., Wang, J., Liu, J. M. (1999). Chromatin Remodeling and Leukemia: New Therapeutic Paradigms. Blood 94: 417-428 [Full Text]  
• Jimenez, M. J. G., Balbin, M., Lopez, J. M., Alvarez, J., Komori, T., Lopez-Otin, C. (1999). Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation. Mol. Cell. Biol. 19: 4431-4442 [Abstract] [Full Text]  
• Mao, S., Frank, R. C., Zhang, J., Miyazaki, Y., Nimer, S. D. (1999). Functional and Physical Interactions between AML1 Proteins and an ETS Protein, MEF: Implications for the Pathogenesis of t(8;21)-Positive Leukemias. Mol. Cell. Biol. 19: 3635-3644 [Abstract] [Full Text]  
• STEIN, G. S., VAN WIJNEN, A. J., STEIN, J. L., LIAN, J. B., POCKWINSE, S. H., MCNEIL, S. (1999). Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions. FASEB J. 13: 157-166 [Abstract] [Full Text]  
• Martiney, M. J., Levy, L. S., Lenz, J. (1999). Suppressor Mutations within the Core Binding Factor (CBF/AML1) Binding Site of a T-Cell Lymphomagenic Retrovirus. J. Virol. 73: 2143-2152 [Abstract] [Full Text]  
• Shi, M.-J., Stavnezer, J. (1998). CBF{alpha}3 (AML2) Is Induced by TGF-{beta}1 to Bind and Activate the Mouse Germline Ig {alpha} Promoter. J. Immunol. 161: 6751-6760 [Abstract] [Full Text]  
• Lutterbach, B., Westendorf, J. J., Linggi, B., Patten, A., Moniwa, M., Davie, J. R., Huynh, K. D., Bardwell, V. J., Lavinsky, R. M., Rosenfeld, M. G., Glass, C., Seto, E., Hiebert, S. W. (1998). ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors. Mol. Cell. Biol. 18: 7176-7184 [Abstract] [Full Text]  
• Kurokawa, M., Mitani, K., Imai, Y., Ogawa, S., Yazaki, Y., Hirai, H. (1998). The t(3;21) Fusion Product, AML1/Evi-1, Interacts With Smad3 and Blocks Transforming Growth Factor-beta -Mediated Growth Inhibition of Myeloid Cells. Blood 92: 4003-4012 [Abstract] [Full Text]  
• Britos-Bray, M., Ramirez, M., Cao, W., Wang, X., Liu, P. P., Civin, C. I., Friedman, A. D. (1998). CBFbeta -SMMHC, Expressed in M4eo Acute Myeloid Leukemia, Reduces p53 Induction and Slows Apoptosis in Hematopoietic Cells Exposed to DNA-Damaging Agents. Blood 92: 4344-4352 [Abstract] [Full Text]  
• Li, J., Tsuji, K., Komori, T., Miyazono, K., Wrana, J. L., Ito, Y., Nifuji, A., Noda, M. (1998). Smad2 Overexpression Enhances Smad4 Gene Expression and Suppresses CBFA1 Gene Expression in Osteoblastic Osteosarcoma ROS17/2.8 Cells and Primary Rat Calvaria Cells. J. Biol. Chem. 273: 31009-31015 [Abstract] [Full Text]  
• Cao, W., Adya, N., Britos-Bray, M., Liu, P. P., Friedman, A. D. (1998). The Core Binding Factor (CBF) alpha  Interaction Domain and the Smooth Muscle Myosin Heavy Chain (SMMHC) Segment of CBFbeta -SMMHC Are Both Required to Slow Cell Proliferation. J. Biol. Chem. 273: 31534-31540 [Abstract] [Full Text]  
• Wigle, D. A., Thompson, K. E., Yablonsky, S., Zaidi, S. H. E., Coulber, C., Jones, P. L., Rabinovitch, M. (1998). AML1-like Transcription Factor Induces Serine Elastase Activity in Ovine Pulmonary Artery Smooth Muscle Cells. Circ. Res. 83: 252-263 [Abstract] [Full Text]  
• Petrovick, M. S., Hiebert, S. W., Friedman, A. D., Hetherington, C. J., Tenen, D. G., Zhang, D.-E. (1998). Multiple Functional Domains of AML1: PU.1 and C/EBPalpha Synergize with Different Regions of AML1. Mol. Cell. Biol. 18: 3915-3925 [Abstract] [Full Text]  
• Ohi, R., Feoktistova, A., McCann, S., Valentine, V., Look, A. T., Lipsick, J. S., Gould, K. L. (1998). Myb-Related Schizosaccharomyces pombe cdc5p Is Structurally and Functionally Conserved in Eukaryotes. Mol. Cell. Biol. 18: 4097-4108 [Abstract] [Full Text]  
• Chen, L.-F., Ito, K., Murakami, Y., Ito, Y. (1998). The Capacity of Polyomavirus Enhancer Binding Protein 2alpha B (AML1/Cbfa2) To Stimulate Polyomavirus DNA Replication Is Related to Its Affinity for the Nuclear Matrix. Mol. Cell. Biol. 18: 4165-4176 [Abstract] [Full Text]  
• Thirunavukkarasu, K., Mahajan, M., McLarren, K. W., Stifani, S., Karsenty, G. (1998). Two Domains Unique to Osteoblast-Specific Transcription Factor Osf2/Cbfa1 Contribute to Its Transactivation Function and Its Inability To Heterodimerize with Cbfbeta. Mol. Cell. Biol. 18: 4197-4208 [Abstract] [Full Text]  
• Lutterbach, B., Sun, D., Schuetz, J., Hiebert, S. W. (1998). The MYND Motif Is Required for Repression of Basal Transcription from the Multidrug Resistance 1 Promoter by the t(8;21) Fusion Protein. Mol. Cell. Biol. 18: 3604-3611 [Abstract] [Full Text]  
• Gamou, T., Kitamura, E., Hosoda, F., Shimizu, K., Shinohara, K., Hayashi, Y., Nagase, T., Yokoyama, Y., Ohki, M. (1998). The Partner Gene of AML1 in t(16;21) Myeloid Malignancies Is a Novel Member of the MTG8(ETO) Family. Blood 91: 4028-4037 [Abstract] [Full Text]  
• Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-j., van Deursen, J. M.A., Harada, H., Downing, J. R. (1998). Expression of a Knocked-In AML1-ETO Leukemia Gene Inhibits the Establishment of Normal Definitive Hematopoiesis and Directly Generates Dysplastic Hematopoietic Progenitors. Blood 91: 3134-3143 [Abstract] [Full Text]  
• Selvamurugan, N., Chou, W.-Y., Pearman, A. T., Pulumati, M. R., Partridge, N. C. (1998). Parathyroid Hormone Regulates the Rat Collagenase-3 Promoter in Osteoblastic Cells through the Cooperative Interaction of the Activator Protein-1 Site and the runt Domain Binding Sequence. J. Biol. Chem. 273: 10647-10657 [Abstract] [Full Text]  
• Erman, B., Cortes, M., Nikolajczyk, B. S., Speck, N. A., Sen, R. (1998). ETS-Core Binding Factor: a Common Composite Motif in Antigen Receptor Gene Enhancers. Mol. Cell. Biol. 18: 1322-1330 [Abstract] [Full Text]  
• Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y., Ogawa, S., Mitani, K., Yazaki, Y., Hirai, H. (1998). The AML1/ETO(MTG8) and AML1/Evi-1 Leukemia-Associated Chimeric Oncoproteins Accumulate PEBP2beta (CBFbeta ) in the Nucleus More Efficiently Than Wild-Type AML1. Blood 91: 1688-1699 [Abstract] [Full Text]  
• Kitabayashi, I., Ida, K., Morohoshi, F., Yokoyama, A., Mitsuhashi, N., Shimizu, K., Nomura, N., Hayashi, Y., Ohki, M. (1998). The AML1-MTG8 Leukemic Fusion Protein Forms a Complex with a Novel Member of the MTG8(ETO/CDR) Family, MTGR1. Mol. Cell. Biol. 18: 846-858 [Abstract] [Full Text]  
• Huang, X., Crute, B. E., Sun, C., Tang, Y.-Y., Kelley III, J. J., Lewis, A. F., Hartman, K. L., Laue, T. M., Speck, N. A., Bushweller, J. H. (1998). Overexpression, Purification, and Biophysical Characterization of the Heterodimerization Domain of the Core-binding Factor beta  Subunit. J. Biol. Chem. 273: 2480-2487 [Abstract] [Full Text]  
• Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., Hiebert, S. W. (1998). The t(8;21) Fusion Product, AML-1-ETO, Associates with C/EBP-alpha , Inhibits C/EBP-alpha -Dependent Transcription, and Blocks Granulocytic Differentiation. Mol. Cell. Biol. 18: 322-333 [Abstract] [Full Text]  
• Tenen, D. G., Hromas, R., Licht, J. D., Zhang, D.-E. (1997). Transcription Factors, Normal Myeloid Development, and Leukemia. Blood 90: 489-519 [Full Text]  
• Zeng, C., van Wijnen, A. J., Stein, J. L., Meyers, S., Sun, W., Shopland, L., Lawrence, J. B., Penman, S., Lian, J. B., Stein, G. S., Hiebert, S. W. (1997). Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc. Natl. Acad. Sci. USA 94: 6746-6751 [Abstract] [Full Text]  
• Niki, M., Okada, H., Takano, H., Kuno, J., Tani, K., Hibino, H., Asano, S., Ito, Y., Satake, M., Noda, T. (1997). Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA 94: 5697-5702 [Abstract] [Full Text]  
• Corsetti, M. T., Calabi, F. (1997). Lineage- and Stage-Specific Expression of Runt Box Polypeptides in Primitive and Definitive Hematopoiesis. Blood 89: 2359-2368 [Abstract] [Full Text]  
• Crute, B. E., Lewis, A. F., Wu, Z., Bushweller, J. H., Speck, N. A. (1996). Biochemical and Biophysical Properties of the Core-binding Factor alpha 2 (AML1) DNA-binding Domain. J. Biol. Chem. 271: 26251-26260 [Abstract] [Full Text]  
• Kurokawa, M., Tanaka, T., Tanaka, K., Hirano, N., Ogawa, S., Mitani, K., Yazaki, Y., Hirai, H. (1996). A Conserved Cysteine Residue in the runt Homology Domain of AML1 Is Required for the DNA Binding Ability and the Transforming Activity on Fibroblasts. J. Biol. Chem. 271: 16870-16876 [Abstract] [Full Text]  
• Armesilla, A. L., Calvo, D., Vega, M. A. (1996). Structural and Functional Characterization of the Human CD36 Gene Promoter. J. Biol. Chem. 271: 7781-7787 [Abstract] [Full Text]  
• Hartwell, L., Kastan, M. (1994). Cell cycle control and cancer. Science 266: 1821-1828 [Abstract]  
• Thirunavukkarasu, K., Halladay, D. L., Miles, R. R., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., Onyia, J. E. (2000). The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function. J. Biol. Chem. 275: 25163-25172 [Abstract] [Full Text]  
• Tang, Y.-Y., Shi, J., Zhang, L., Davis, A., Bravo, J., Warren, A. J., Speck, N. A., Bushweller, J. H. (2000). Energetic and Functional Contribution of Residues in the Core Binding Factor beta (CBFbeta ) Subunit to Heterodimerization with CBFalpha. J. Biol. Chem. 275: 39579-39588 [Abstract] [Full Text]  
• Li, P.-X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., Klamut, H. J. (2000). Placental Transforming Growth Factor-beta Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression. J. Biol. Chem. 275: 20127-20135 [Abstract] [Full Text]